General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children
2022 End of Year Message from the President of the Penta Foundation, Carlo Giaquinto
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project
Path towards efficient paediatric formulation development based on partnering with clinical pharmacologists and clinicians, a conect4children expert group white paper
c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper
The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts
Get to know the UNIVERSAL project: Assessing the long-term safety of ART drugs
PentaTr@ining: ‘Fungal Infections in Paediatrics’ online course wraps up!
Implementation of infection prevention and control for hospitalised neonates: A narrative review
WHO publishes the AWaRe (Access, Watch, Reserve) Antibiotic Book
Experts call for urgent action to develop antibiotics for newborns
🇬🇧 Experts call for urgent action to develop antibiotics for newborns
‘PentaTr@ining: Viral Hepatitis in Children’ – online course launches!
World AIDS Day 2022: Is HIV cure attainable in our lifetime?
Understanding paediatric data standards challenges through academia-industry partnerships: A conect4children (c4c) qualitative study
Antibiotics needed to treat multidrug-resistant infections in neonates
